OTCMKTS:MPSYF

MorphoSys - MPSYF Stock Forecast, Price & News

$18.85

+0.82 (+4.55%)

(As of 01/24/2023)

Add

Compare

Today's Range: $18.85
▼
$18.85
50-Day Range: $16.55
▼
$18.85
52-Week Range: $13.84
▼
$30.88

Volume: 100 shs
Average Volume: 1,075 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About MorphoSys (OTCMKTS:MPSYF) Stock

MorphoSys AG operates as a commercial-stage biopharmaceutical company. It uses groundbreaking science and technologies to discover, develop, and deliver innovative cancer medicines to patients. The firm also engages in the development and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.

Receive MPSYF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MorphoSys and its competitors with MarketBeat's FREE daily newsletter.

MPSYF Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

30 days | 90 days | 365 days | Advanced Chart

Receive MPSYF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MorphoSys and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:MPSYF
CUSIP: N/A
CIK: 1340243
Web: www.morphosys.com
Phone: (498) 989-9270
Fax: N/A
Employees: 732
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Executives

Jean-Paul Kress
CEO & Chairman-Management Board

Tim Demuth
Chief Research & Development Officer

Luisa Ciccarelli
Global Head-Technical Operations & Senior VP

Ralf Ostendorp
Senior Vice President, Head-Protein Sciences & CMC

Maria Castresana
Senior VP & Global Head-Human Resources

Key Competitors

View All Competitors

MPSYF Stock - Frequently Asked Questions

How have MPSYF shares performed in 2023?: MorphoSys' stock was trading at $14.18 at the beginning of the year. Since then, MPSYF shares have increased by 21.9% and is now trading at $17.29.
View the best growth stocks for 2023 here.
What is MorphoSys' stock symbol?: MorphoSys trades on the OTCMKTS under the ticker symbol "MPSYF."

How do I buy shares of MorphoSys?: Shares of MPSYF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is MorphoSys' stock price today?: One share of MPSYF stock can currently be purchased for approximately $17.29.
How many employees does MorphoSys have?: The company employs 732 workers across the globe.
How can I contact MorphoSys?: MorphoSys' mailing address is Semmelweisstrasse 7, Planegg, Bayern (Bavaria). The official website for the company is www.morphosys.com. The company can be reached via phone at (498) 989-9270.

This page (OTCMKTS:MPSYF) was last updated on 3/27/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial